Matches in Wikidata for { <http://www.wikidata.org/entity/Q89155210> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q89155210 description "clinical trial" @default.
- Q89155210 description "ensayu clínicu" @default.
- Q89155210 description "klinisch onderzoek" @default.
- Q89155210 description "клінічне випробування" @default.
- Q89155210 name "Study to Assess the Immunogenicity and Safety of GSK's Meningococcal Group B Vaccine When Administered Concomitantly With GSK's Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age" @default.
- Q89155210 name "Study to Assess the Immunogenicity and Safety of GSK's Meningococcal Group B Vaccine When Administered Concomitantly With GSK's Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age" @default.
- Q89155210 type Item @default.
- Q89155210 label "Study to Assess the Immunogenicity and Safety of GSK's Meningococcal Group B Vaccine When Administered Concomitantly With GSK's Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age" @default.
- Q89155210 label "Study to Assess the Immunogenicity and Safety of GSK's Meningococcal Group B Vaccine When Administered Concomitantly With GSK's Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age" @default.
- Q89155210 prefLabel "Study to Assess the Immunogenicity and Safety of GSK's Meningococcal Group B Vaccine When Administered Concomitantly With GSK's Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age" @default.
- Q89155210 prefLabel "Study to Assess the Immunogenicity and Safety of GSK's Meningococcal Group B Vaccine When Administered Concomitantly With GSK's Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age" @default.
- Q89155210 P1132 Q89155210-D32CB073-286D-44B1-BAAC-CBB51E8D3D64 @default.
- Q89155210 P1476 Q89155210-6A526536-B871-4535-A67E-7B1D94C51808 @default.
- Q89155210 P2283 Q89155210-F509C8DC-5D00-4392-A946-7AE78B81A539 @default.
- Q89155210 P2899 Q89155210-F0371AA0-CAA7-4AEC-92DC-C203D3573325 @default.
- Q89155210 P3098 Q89155210-93BE00B2-F3F1-485B-B551-A4E38BB50E41 @default.
- Q89155210 P31 Q89155210-C96FD4D8-2334-4764-95CF-73CEAFB054E6 @default.
- Q89155210 P4135 Q89155210-CD3E6FA3-D273-4E2E-8C46-2966D3762284 @default.
- Q89155210 P580 Q89155210-6B29AE02-B30F-41EA-A6F7-395E1A9FDAC4 @default.
- Q89155210 P582 Q89155210-D9623268-3B16-43F9-8A9D-C19ACA54F613 @default.
- Q89155210 P6099 Q89155210-4404B55D-F211-4F46-8145-AF1AAB45E743 @default.
- Q89155210 P8363 Q89155210-4009F209-0183-478A-B130-4F71D9BE1088 @default.
- Q89155210 P859 Q89155210-BF8CE3ED-0DBE-4FDB-8697-784944C59AEB @default.
- Q89155210 P1132 "+945" @default.
- Q89155210 P1476 "A Phase IIIB, Randomized, Observer-blind, Multicenter Study to Assess the Safety and Immunogenicity of GSK's Meningococcal Group B Vaccine When Administered Concomitantly With GSK's Meningococcal MenACWY Conjugate Vaccine to Healthy Subjects of 16-18 Years of Age" @default.
- Q89155210 P2283 Q73214260 @default.
- Q89155210 P2899 "+16" @default.
- Q89155210 P3098 "NCT04318548" @default.
- Q89155210 P31 Q30612 @default.
- Q89155210 P4135 "+18" @default.
- Q89155210 P580 "2020-05-04T00:00:00Z" @default.
- Q89155210 P582 "2022-03-31T00:00:00Z" @default.
- Q89155210 P6099 Q42824827 @default.
- Q89155210 P8363 Q78089383 @default.
- Q89155210 P859 Q212322 @default.